Annual Operating Expenses
$118.19 M
+$33.34 M+39.29%
December 31, 2021
Summary
- As of February 8, 2025, PHAS annual total operating expenses is $118.19 million, with the most recent change of +$33.34 million (+39.29%) on December 31, 2021.
- During the last 3 years, PHAS annual operating expenses has risen by +$97.88 million (+481.89%).
Performance
PHAS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$25.52 M
+$7.17 M+39.11%
June 30, 2022
Summary
- As of February 8, 2025, PHAS quarterly total operating expenses is $25.52 million, with the most recent change of +$7.17 million (+39.11%) on June 30, 2022.
- Over the past year, PHAS quarterly operating expenses has stayed the same.
Performance
PHAS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PHAS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.3% | 0.0% |
| 3 y3 years | +481.9% | 0.0% |
| 5 y5 years | +1284.3% | 0.0% |
PHAS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -20.9% | -28.1% |
| 5 y | 5-year | at high | -64.4% | -20.9% | -48.5% |
| alltime | all time | at high | -92.8% | -20.9% | -92.6% |
PhaseBio Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $25.52 M(+39.1%) |
| Mar 2022 | - | $18.34 M(-43.1%) |
| Dec 2021 | $118.19 M(+39.3%) | $32.24 M(+11.5%) |
| Sep 2021 | - | $28.91 M(-7.9%) |
| Jun 2021 | - | $31.39 M(+22.4%) |
| Mar 2021 | - | $25.65 M(-1.3%) |
| Dec 2020 | $84.86 M(+101.6%) | $25.98 M(+26.8%) |
| Sep 2020 | - | $20.49 M(-15.0%) |
| Jun 2020 | - | $24.10 M(+65.0%) |
| Mar 2020 | - | $14.61 M(+11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $42.10 M(+107.3%) | $13.14 M(+13.4%) |
| Sep 2019 | - | $11.59 M(+13.8%) |
| Jun 2019 | - | $10.19 M(+26.7%) |
| Mar 2019 | - | $8.04 M(-3.5%) |
| Dec 2018 | $20.31 M(+137.9%) | $8.33 M(+66.6%) |
| Sep 2018 | - | $5.00 M(+21.7%) |
| Jun 2018 | - | $4.11 M(+42.7%) |
| Mar 2018 | - | $2.88 M(+17.4%) |
| Dec 2017 | $8.54 M(-10.1%) | $2.45 M(+29.3%) |
| Sep 2017 | - | $1.90 M |
| Dec 2016 | $9.50 M | - |
FAQ
- What is PhaseBio Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual operating expenses year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly operating expenses year-on-year change?
What is PhaseBio Pharmaceuticals annual total operating expenses?
The current annual operating expenses of PHAS is $118.19 M
What is the all time high annual operating expenses for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual total operating expenses is $118.19 M
What is PhaseBio Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, PHAS annual total operating expenses has changed by +$33.34 M (+39.29%)
What is PhaseBio Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of PHAS is $25.52 M
What is the all time high quarterly operating expenses for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly total operating expenses is $32.24 M
What is PhaseBio Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, PHAS quarterly total operating expenses has changed by $0.00 (0.00%)